StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) income statement

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.96−0.02 (-1.01%)

Close on Nov 20, 2026Market cap $124.85MP/E –Yield –

See a number that looks wrong?